Obesity and nonalcoholic fatty liver disease

scientific article published on June 2007

Obesity and nonalcoholic fatty liver disease is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1753-4887.2007.TB00329.X
P698PubMed publication ID17605315
P5875ResearchGate publication ID6232945

P2093author name stringPaul Angulo
P433issue6 Pt 2
P921main subjectobesityQ12174
metabolic dysfunction–associated steatotic liver diseaseQ1546498
fatty liver diseaseQ6058862
P304page(s)S57-63
P577publication date2007-06-01
P1433published inNutrition ReviewsQ15765213
P1476titleObesity and nonalcoholic fatty liver disease
P478volume65

Reverse relations

cites work (P2860)
Q37789176Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.
Q30403032Accuracy of computer-aided ultrasound as compared with magnetic resonance imaging in the evaluation of nonalcoholic fatty liver disease in obese and eutrophic adolescents
Q33661588Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis
Q36309443Adipocyte hypertrophy is associated with lysosomal permeability both in vivo and in vitro: role in adipose tissue inflammation
Q43289285Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery
Q34834198Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease
Q39596890Anti-inflammatory effect of insulin in the human hepatoma cell line HepG2 involves decreased transcription of IL-6 target genes and nuclear exclusion of FOXO1.
Q38481462Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?
Q34864638Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis
Q37550329Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice
Q36707649Cardiorespiratory fitness, waist circumference, and alanine aminotransferase in youth
Q37196525Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention
Q38868400Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood
Q28478084Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates
Q38781112Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice
Q92502893Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Q41580240Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
Q40818105Ethanol extract of Cirsium japonicum attenuates hepatic lipid accumulation via AMPK activation in human HepG2 cells
Q37237978Exploration of a symptoms experience in people with obesity-related nonalcoholic fatty liver disease.
Q35550630Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease
Q36339285Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism
Q35040090Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease
Q36788693Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.
Q41872219Hepatic angiogenesis and fibrosis are common features in morbidly obese patients.
Q34614334Hepatic methionine homeostasis is conserved in C57BL/6N mice on high-fat diet despite major changes in hepatic one-carbon metabolism
Q42330055Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade
Q59131888High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype
Q37257204High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model
Q50434312Improvements of Glucose and Lipid Metabolism After Jejuno-ileal Circuit Procedure in a Non-obese Diabetic Rat Model.
Q36001686Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
Q36151646Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease
Q47744258Influence of dietary macronutrients on liver fat accumulation and metabolism.
Q64355676Insights into the Role of PPARβ/δ in NAFLD
Q37655272Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and promote metabolic impairment after new challenge to high-fat diet
Q34103693Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease
Q59353752Liver Attenuation, Pericardial Adipose Tissue, Obesity, and Insulin Resistance: The Multi-Ethnic Study of Atherosclerosis (MESA)
Q37721939Liver fat content determined by magnetic resonance imaging and spectroscopy
Q49376054MicroRNA-125a-5p Mediates 3T3-L1 Preadipocyte Proliferation and Differentiation.
Q33612997MicroRNAs in metabolism and metabolic disorders
Q33890230Molecular pathways in non-alcoholic fatty liver disease.
Q53695403Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
Q34578790Non-alcoholic fatty liver disease proteomics
Q33855157Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.
Q46054372Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis
Q35874842Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
Q33578954Obesity-induced hepatic steatosis is mediated by endoplasmic reticulum stress in the subfornical organ of the brain
Q41457655Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.
Q48955354Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients.
Q33748493Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children
Q34415002Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units
Q41274133Prevalence of extreme obesity in a multiethnic cohort of children and adolescents
Q92974229Quantitative Evaluation of Hepatic Steatosis Using Normalized Local Variance in a Rat Model: Comparison with Histopathology as the Reference Standard
Q34243636Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis
Q35900825Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice
Q26775340Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
Q46335395Retinol and alpha-tocopherol in morbid obesity and nonalcoholic fatty liver disease.
Q38353525Role of fish oil in human health and possible mechanism to reduce the inflammation
Q88654483Roles of Perilipins in Diseases and Cancers
Q42361156Serum and Liver Tissue Metabonomic Study on Fatty Liver in Rats Induced by High-Fat Diet and Intervention Effects of Traditional Chinese Medicine Qushi Huayu Decoction
Q37353943Steatocholecystitis and fatty gallbladder disease
Q34088181Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells
Q33594205Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida
Q36606602The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease
Q90749894The Potential of the FSP1cre-Pparb/d-/- Mouse Model for Studying Juvenile NAFLD
Q26777980The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis
Q45244529Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
Q90094530United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts
Q43168054Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients

Search more.